PATIENTS RECEIVING LOW-DOSE ACETYLSALICYLIC ACID THERAPY WHO ARE AT HIGH RISK OF UPPER GASTROINTESTINAL BLEEDING OFTEN DO NOT RECEIVE CONCOMITANT GASTROPROTECTION

(1) Centro Español de Investigación Farmacoepidemiológica, CEIFE, Madrid, Spain

(2) AstraZeneca R&DMölndal, Mölndal, Sweden

(3) CEIFE Centro Español, de Investigación, Farmacoepidemiológia, Madrid, Spain



This item was part of the GI bleeding: Risk factors and natural history session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A61